| American Journal of Translational Research | |
| The role of IL-27 in the induction of anti-tumor cytotoxic T lymphocyte response | |
| Zhenzhen Liu1  | |
| 关键词: IL-27; anti-tumor cytotoxic T lymphocyte (CTLs); cancer; p28; p35; p53; IL-21; | |
| DOI : | |
| 学科分类:医学(综合) | |
| 来源: e-Century Publishing Corporation | |
PDF
|
|
【 摘 要 】
Cytotoxic T lymphocyte (CTL) response is a critical component of the immune response to tumors, therefore optimal induction of CTL responses to tumor antigens is highly desired for developing efficient cancer immunotherapy. IL-27 is a member of the IL-12 family of cytokines that is comprised of an IL-12 p40-related protein subunit, EBV-induced gene 3 (EBI3), and a p35-related subunit, p28. IL-27 functions through IL-27R and has been shown to have potent anti-tumor activity via activation of a variety of immune components, including anti-tumor CD8+ T cell responses. However, the exact mechanisms of how IL-27 enhances anti-tumor CD8+ T cell responses are not fully understood. In this paper we mainly discuss the evidences that suggest novel mechanisms by which IL-27 enhances anti-tumor CTL responses, including IL-27 inhibition of activation-induced cell death; the phenotypes of IL-27-stimulated CTLs; IL-27-induced CTL IL-10/IL-21 production and IL-27-mediated suppression of regulatory T cell responses. These evidences suggest that IL-27 may have a great potential to be utilized in boosting anti-tumor CTL responses in human cancer patients.
【 授权许可】
CC BY-NC
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO201904031019501ZK.pdf | 565KB |
PDF